Media 280723

CTO Mr Craig Weller said on Aqua Phase studies revealing the absorption of CBD as more than 4 times greater than CBD in oil:
Bod has been sweating on the PK study for months. It needed to show improved bioavailability of 30% for the deal to proceed, it exceeded by a factor of 10, what this means is that if we ingest 100mg of CBD in oil, we will normally absorb 6-8% of the dose. With Aqua Phase, the CBD absorption is 32% This means we can either get a better response to the CBD or otherwise we can reduce the Aqua Phase dose – giving potentially less side effects and providing CBD raw material savings.
Bod Australia reveals ‘significant’ growth in medicinal cannabis prescriptions, more to come
25 Jul 2019
Published by: Small Caps
Swisse owner hopes China's 'clean green' love affair extends to hemp
23 Jul 2019
Published by: Australian Financial Review
Bod Australia receives major capital boost via Health & Happiness Group's innovation arm
19 Jul 2019
Published by: Small Caps
BOD Share Price Climbs 45% with New Strategic Investment Deal
19 Jul 2019
Published by: Money Morning
Bod Australia’s cannabis oil to be used in landmark PTSD trial
04 Jun 2019
Published by: Small Caps
Pharma at home, supplements abroad: Bod Australia's twin strategy for CBD success underlined by new Tourette's trial
17 Apr 2019
Published by: Nutra Indrediants Asia
Medical cannabis play Bod lands its first deal to sell its health products overseas
11 Mar 2019
Published by: Stockhead
CBD and nootropics boom: Bod Australia reveals record revenue and expansion aims
23 Jan 2019
Published by: Nutra Indrediants Asia